Policy paper

vCJD and transfusion of blood components: updated risk assessment

Paper on the transmission of variant vCJD from person to person though receipt of donated blood components.

Documents

vCJD and transfusion of blood components: an updated risk assessment

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format please email publications@dh.gsi.gov.uk quoting your address, telephone number along with the title of the publication ("vCJD and transfusion of blood components: an updated risk assessment").

Annexes to vCJD and transfusion of blood components: an updated risk assessment

This file may not be suitable for users of assistive technology. Request a different format.

If you use assistive technology and need a version of this document in a more accessible format please email publications@dh.gsi.gov.uk quoting your address, telephone number along with the title of the publication ("Annexes to vCJD and transfusion of blood components: an updated risk assessment ").

Detail

This risk assessment presents a mathematical model, primarily designed to examine how many future clinical cases might be caused in this way.

Key inputs to the model include the number of donors that might be carrying Creutzfeldt-Jakob Disease (vCJD) infection without showing any symptoms, the infective dose in blood components sourced from such a donor and the likelihood of recipients surviving long enough to develop symptoms of vCJD if infected.

Help us improve GOV.UK

Please don't include any personal or financial information, for example your National Insurance or credit card numbers.